Showcases Stock ranks Forex

Geron Corp (GERN)
1.45  -0.01 (-0.68%) 10-22 16:00
Open: 1.46 Pre. Close: 1.46
High: 1.47 Low: 1.42
Volume: 1,054,206 Market Cap: 465M
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for hematologic myeloid malignancies. It holds rights to imetelstat, a telomerase inhibitor in Phase 2/3 clinical trials, which inhibits the uncontrolled proliferation of malignant progenitor cells in hematologic myeloid malignancies to reduce dysfunctional blood cell production and enable recovery of normal blood cell production. The company was founded in 1990 and is headquartered in Menlo Park, California.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 1.472 - 1.48 1.48 - 1.486
Low: 1.403 - 1.411 1.411 - 1.417
Close: 1.439 - 1.451 1.451 - 1.461
Stock Technical Analysis
Target: Six months: 1.73
One year: 2.02
Support: Support1: 1.37
Support2: 1.31
Resistance: Resistance1: 1.48
Resistance2: 1.73
Pivot: 1.39
Moving Averages: MA(5): 1.45
MA(20): 1.39
MA(100): 1.37
MA(250): 1.56
MACD: MACD(12,26): 0.02
Signal(12,26,9): 0.01
%K %D: %K(14,3): 86.03
%D(3): 85.01
RSI: RSI(14): 58.28
52-Week: High: 2.36
Low: 1.2
Change(%): -20.8
Average Vol(K): 3-Month: 170970
10-Days: 152178
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.

GERN has closed below upper band by 21.5%. Bollinger Bands are 11.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Thu, 21 Oct 2021
Geron (GERN) gains 0.69% in Light Trading on October 21 -

Fri, 24 Sep 2021
Geron (GERN) falls 5.52% on Moderate Volume September 24 -

Fri, 20 Aug 2021
Should You Buy Geron Corporation (GERN) Stock on Friday? - InvestorsObserver

Thu, 05 Aug 2021
Geron to Announce Second Quarter 2021 Financial Results on August 16, 2021 - Business Wire

Fri, 18 Jun 2021
GERN Stock Price Increases Over 30% Pre-Market: Why It Happened - Pulse 2.0

Thu, 20 May 2021
Could The Geron Corporation (NASDAQ:GERN) Ownership Structure Tell Us Something Useful? - Simply Wall St

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 318.57
Shares Float (M) 287.90
% Held by Insiders 0.17
% Held by Institutions 46.28
Shares Short (K) 26840
Shares Short Prior Month (K) 25950
Stock Financials
EPS -0.288
Book Value (p.s.) 0.630
Profit Margin
Operating Margin -26182.54
Return on Assets (ttm) -27.5
Return on Equity (ttm) -54.1
Qtrly Rev. Growth 163.5
Gross Profit (p.s.) -0.156
Sales Per Share 0.001
EBITDA (p.s.) -0.277
Qtrly Earnings Growth
Operating Cash Flow (M) -73.19
Levered Free Cash Flow (M) -38.67
Stock Valuation
PE Ratio -5.03
PEG Ratio
Price to Book value 2.30
Price to Sales 1366.65
Price to Cash Flow -6.31
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator